Review
Open access
Sep 2026
From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies.
The role of EGFRvIII in driving aggressive tumor growth is discussed and how effective targeting of EGFRvIII, and overcoming resistance mutations will be crucial to improve EGFR- and EGFRvIII-based therapies are highlighted.
U. Krishnaja, N. J, Maitheli Sarkar et al.
· Immunotherapy · 0 citations